By Counterforce Health Team in Natpara (parathyroid hormone) —

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in Texas: Appeals Guide for Discontinued Drug

Answer Box: Getting Natpara (Parathyroid Hormone) Covered by Cigna in Texas

Important: Natpara was discontinued by Takeda in December 2024, with the U.S. Special Use Program ending December 31, 2025. New prescriptions are no longer available. However, if you received a Cigna denial for Natpara before discontinuation or need coverage for alternative treatments like Yorvipath, you can appeal within 180 days in Texas. Submit your first-level appeal through Cigna's provider portal with medical necessity documentation, then escalate to Texas Department of Insurance external review if denied. Start by gathering your denial letter, clinical notes, and endocrinologist support letter today.

Table of Contents

  1. Understanding Natpara's Current Status
  2. Reading Your Cigna Denial Letter
  3. Common Fixable Issues
  4. First-Level Appeal Process
  5. Peer-to-Peer Review Strategy
  6. Second-Level & External Review in Texas
  7. Appeal Templates and Scripts
  8. Tracking Your Appeal
  9. Alternative Treatment Options
  10. FAQ

Understanding Natpara's Current Status

Natpara (parathyroid hormone) was discontinued globally by Takeda at the end of 2024, with the U.S. Special Use Program officially ending December 31, 2025. This means no new prescriptions are being filled, and all existing patients must transition to alternative treatments.

However, if you received a Cigna denial for Natpara before the discontinuation or need coverage for alternative hypoparathyroidism treatments, the appeal process remains relevant. Understanding your rights under Texas insurance law is crucial for securing coverage for replacement therapies.

Coverage at a Glance: Natpara and Alternatives

Requirement What It Means Current Status Source
FDA Approval Chronic hypoparathyroidism treatment Natpara discontinued; Yorvipath approved 2024 FDA
Cigna PA Required Prior authorization needed Yes for alternatives Cigna Policy
Step Therapy Try conventional therapy first Required: calcium + calcitriol Cigna
Appeal Deadline Time to file internal appeal 180 days from denial Texas DOI
External Review Independent review option Available after internal appeals Texas IRO

Reading Your Cigna Denial Letter

Your Cigna denial letter contains critical information for building your appeal. Look for these key elements:

Denial Reason Codes:

  • Medical necessity: Cigna determined treatment wasn't medically necessary
  • Non-formulary: Drug not on Cigna's preferred list
  • Step therapy: Must try other treatments first
  • Quantity limits: Prescribed amount exceeds coverage limits

Important Dates:

  • Denial date (starts your 180-day appeal clock)
  • Service dates
  • Appeal deadline

Reference Numbers:

  • Claim number
  • Prior authorization number
  • Member ID
Tip: If your denial mentions "discontinued" or "not available," this likely refers to Natpara's manufacturing halt. You can still appeal for alternative treatments.

Common Fixable Issues

Before filing a formal appeal, check if your denial stems from easily correctable issues:

Missing Documentation

  • Problem: Incomplete prior authorization request
  • Fix: Submit complete clinical notes, lab results, and treatment history
  • Timeline: 1-3 business days

Incorrect Coding

  • Problem: Wrong diagnosis or procedure codes
  • Fix: Have your provider resubmit with correct ICD-10 codes (E20.x for hypoparathyroidism)
  • Timeline: 5-10 business days

Benefit vs. Medical Policy Confusion

  • Problem: Denial under wrong policy section
  • Fix: Clarify whether this is a pharmacy or medical benefit issue
  • Contact: Cigna customer service at 1-800-244-6224

First-Level Appeal Process

Step-by-Step: Filing Your Cigna Appeal

  1. Gather Required Documents (Patient/Clinic)
    • Denial letter
    • Complete medical records (6+ months)
    • Lab results showing hypocalcemia and low PTH
    • Treatment failure documentation
    • Timeline: 3-5 days to collect
  2. Request Medical Necessity Letter (Clinic)
  3. Submit Appeal (Clinic/Patient)
    • Use Cigna provider portal or fax number on denial letter
    • Include all supporting documentation
    • Timeline: Submit within 180 days of denial
  4. Follow Up (Patient)
    • Call within 5-7 days to confirm receipt
    • Request peer-to-peer review
    • Timeline: 30 days for decision (commercial plans)

Medical Necessity Letter Checklist

Your endocrinologist's letter should include:

  • Diagnosis: Chronic hypoparathyroidism with ICD-10 code
  • Lab Evidence: Low/absent PTH, hypocalcemia, normal magnesium
  • Treatment History: Failed high-dose calcium and calcitriol therapy
  • Symptoms: Muscle cramps, paresthesias, seizures, quality of life impact
  • Clinical Rationale: Why PTH replacement is necessary
  • Monitoring Plan: Calcium levels, renal function assessment

Peer-to-Peer Review Strategy

Request a peer-to-peer call within 5-7 days of submitting your appeal. This allows your doctor to speak directly with Cigna's medical director.

Preparation Checklist for Your Doctor

  • Key Points to Emphasize:
    • Chronic hypoparathyroidism diagnosis confirmed by labs
    • Failure of conventional therapy (calcium + calcitriol)
    • Persistent symptoms affecting daily function
    • Natpara discontinuation creates treatment gap
  • Have Ready:
    • Patient's complete medical history
    • Recent lab values
    • Documentation of treatment failures
    • Alternative treatment options (Yorvipath)

Sample Talking Points

"This patient has chronic hypoparathyroidism confirmed by persistently low PTH levels below 15 pg/mL and symptomatic hypocalcemia. Despite optimized conventional therapy with high-dose calcium carbonate and calcitriol, they continue to experience muscle cramps and require frequent dose adjustments. The European Society of Endocrinology guidelines support PTH replacement therapy for patients who cannot be adequately controlled on conventional treatment."

Second-Level & External Review in Texas

If Cigna denies your first-level appeal, Texas law provides additional options.

Internal Second-Level Appeal

  • Deadline: File within 60 days of first-level denial
  • Process: Same as first-level but reviewed by different medical director
  • Timeline: 30 days for decision

Texas External Review (IRO)

Texas Department of Insurance offers independent external review through certified Independent Review Organizations (IROs).

Eligibility:

  • Exhausted internal appeals (or filed exemption request)
  • Denial based on medical necessity or experimental/investigational status
  • State-regulated health plan (not self-funded ERISA plans)

Process:

  1. Request Form: Call TDI at 1-800-252-3439 or download from TDI website
  2. Submit Within: 4 months of final internal denial
  3. Required Documents:
    • Final denial letter
    • All medical records
    • Physician attestation letter
  4. Decision Timeline: 20 days (5 days if urgent)
  5. Binding: IRO decision is final and binding on Cigna
Note: The IRO process is free to patients - Cigna pays the review fee.

Appeal Templates and Scripts

Patient Phone Script for Cigna

"Hello, I'm calling about a prior authorization denial for Natpara. My member ID is [ID number]. I received a denial dated [date] with reference number [number]. I understand Natpara was discontinued, but I'd like to discuss coverage for alternative treatments for my chronic hypoparathyroidism. Can you help me understand the appeal process and any formulary exceptions available?"

Email Template for Clinical Documentation

Subject: Urgent: Clinical Records Needed for Insurance Appeal - [Patient Name]

"Dear [Doctor's Office],

I need complete medical records for my insurance appeal for hypoparathyroidism treatment. Please provide:

  • Last 12 months of endocrinology visit notes
  • All relevant lab results (calcium, PTH, phosphorus, magnesium)
  • Documentation of failed treatments
  • Current medication list

My appeal deadline is [date]. Please fax to [number] or email securely. Thank you for your help."

Tracking Your Appeal

Appeal Log Template

Date Action Taken Contact Person Reference # Follow-up Date Status
[Date] Submitted first appeal Cigna Appeals [Ref #] [Date + 7 days] Pending
[Date] Called for status [Rep name] [Call ref] [Date + 5 days] In review

When to Escalate

File TDI Complaint if:

  • Appeals exceed stated timeframes
  • Cigna fails to provide required forms
  • Procedural violations occur

Contact Information:

Alternative Treatment Options

With Natpara discontinued, focus your appeals on these alternatives:

Yorvipath (Palopegteriparatide)

  • Status: FDA-approved 2024 for chronic hypoparathyroidism
  • Cigna Coverage: Likely requires prior authorization
  • Strategy: Emphasize FDA approval and Natpara discontinuation in appeals

Optimized Conventional Therapy

  • Components: High-dose calcium carbonate + calcitriol
  • Additions: Thiazide diuretics for hypercalciuria
  • Monitoring: Regular calcium, phosphorus, and renal function checks

Patient Assistance Programs

From Our Advocates: We've seen success when patients work closely with their endocrinologist to document the specific ways conventional therapy has failed - not just lab values, but real impacts on daily life like missed work due to muscle cramps or emergency room visits for severe hypocalcemia. This functional impairment documentation often makes the difference in appeals.

When navigating insurance denials for rare disease treatments, having expert support can make all the difference. Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, identifying specific policy requirements, and crafting evidence-backed rebuttals. Their platform helps patients, clinicians, and specialty pharmacies get prescription drugs approved by targeting the exact criteria payers use to make coverage decisions.

FAQ

Q: How long does a Cigna prior authorization appeal take in Texas? A: First-level appeals typically take 30 days for commercial plans. Expedited appeals are decided within 72 hours if delay would jeopardize your health.

Q: Can I appeal if Natpara is completely discontinued? A: Yes, you can appeal for alternative treatments like Yorvipath or request formulary exceptions for off-label uses of other medications.

Q: What if my plan is through my employer? A: Self-funded ERISA plans follow federal appeal rules, not Texas state requirements. Check your plan documents for specific appeal procedures.

Q: Does step therapy apply if I tried treatments in another state? A: Yes, treatment history from any licensed provider should count. Include all medical records in your appeal.

Q: How much does external review cost? A: External review through Texas IRO is free to patients - the insurance company pays all fees.

Q: What happens if I miss the appeal deadline? A: You may lose your right to appeal that specific denial. However, you can request a new prior authorization and start the process over.

Q: Can I request an expedited appeal? A: Yes, if a delay in treatment would seriously jeopardize your health. Your doctor must certify the urgency.

Q: What if Cigna doesn't respond within the required timeframe? A: File a complaint with Texas Department of Insurance and proceed to external review if eligible.

For the most current information on appeals and alternative treatments, Counterforce Health provides updated guides and personalized support for complex insurance denials, helping ensure patients get access to the treatments they need.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and state regulations may change. Always consult with your healthcare provider and insurance company for the most current information regarding your specific situation. For personalized help with insurance appeals, contact the Texas Department of Insurance at 1-800-252-3439.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.